GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Operating Margin %

WPD Pharmaceuticals (XCNQ:WBIO) Operating Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. WPD Pharmaceuticals's Operating Income for the three months ended in Dec. 2023 was C$0.00 Mil. WPD Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was C$0.00 Mil. Therefore, WPD Pharmaceuticals's Operating Margin % for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for WPD Pharmaceuticals's Operating Margin % or its related term are showing as below:


XCNQ:WBIO's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -168.01
* Ranked among companies with meaningful Operating Margin % only.

WPD Pharmaceuticals's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

WPD Pharmaceuticals's Operating Income for the three months ended in Dec. 2023 was C$0.00 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.27 Mil.

Warning Sign:

WPD Pharmaceuticals Inc had lost money in 83% of the time over the past 12quarters.


WPD Pharmaceuticals Operating Margin % Historical Data

The historical data trend for WPD Pharmaceuticals's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Operating Margin % Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WPD Pharmaceuticals's Operating Margin %

For the Biotechnology subindustry, WPD Pharmaceuticals's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Operating Margin % distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Operating Margin % falls into.



WPD Pharmaceuticals Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

WPD Pharmaceuticals's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0 / 0
= %

WPD Pharmaceuticals's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WPD Pharmaceuticals  (XCNQ:WBIO) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


WPD Pharmaceuticals Operating Margin % Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals (XCNQ:WBIO) Business Description

Traded in Other Exchanges
N/A
Address
750 West Pender Street, Suite 401, Vancouver, BC, CAN, V6C 2T7
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.

WPD Pharmaceuticals (XCNQ:WBIO) Headlines

No Headlines